Tech Company Financing Transactions
NLS Pharmaceutics Funding Round
NLS Pharmaceutics closed a $1 million investment round on 6/30/2025. Backers included private investors.
Transaction Overview
Company Name
Announced On
6/30/2025
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
The Circle 6 | P.O. Box
Zurich, CH - 8058
Switzerland
Zurich, CH - 8058
Switzerland
Phone
Website
Email Address
Overview
Our Vision: Awaken a brighter future for patients by overcoming rare and complex CNS diseases. Our Mission: To Develop Better Therapies to Safeguard and Empower the Brain throughout all Stages of Life. NLS was formed in June 2015 in Stans, Switzerland, and is a Swiss limited company. In 2016, we acquired several patents from Assistance Publique -- Hopitaux de Paris, or AP-HP in France, including intellectual property for our lead compound, mazindol.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alex Zwyer
Browse more venture capital transactions:
Prev: 6/30/2025: Audos venture capital transaction
Next: 6/30/2025: CRED Platform venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs